Canadian Prime Minister Steven Harper presented the investment from the
Atlantic Canada Opportunities Agency (ACOA) to Delivra, Inc. CEO Dr.
BURLINGTON, ON, May 15, 2013 /CNW/ - Delivra, Inc., the Canadian-based
manufacturer and market leader in transdermal delivery technology,
announces the investment from the Atlantic Canada Opportunities Agency
(ACOA). The $2.86 million investment from ACOA's core funding program,
Atlantic Innovation Fund (AIF), enables Delivra, Inc. to strengthen and expand its novel delivery
system Delivra™ through research and development. Canadian Prime
Minister Steven Harper personally presented Delivra, Inc. CEO Dr. Joseph Gabriele with the investment.
Minister Gail Shea described the investment in terms of shaping Atlantic Canada's
knowledge economy, "Our Government is focused on jobs, growth and
long-term prosperity. By investing in R&D and innovative companies like
Delivra Inc., we will position Atlantic Canada to succeed in the
knowledge economy of the 21st century by building more productive,
globally competitive companies. These companies will create wealth,
more jobs and a greater quality of life in our region."
"This investment by the Atlantic Innovation Fund will allow our
innovative Canadian company to hire full time employees on Prince
Edward Island. This enables us to implement, validate and
commercialize the cutting edge science behind our
non- prescription transdermal cream products distributed nationally
through pharmacy . Specifically, AIF's funding will be instrumental to
improve health and wellness for those suffering from inflammatory and
other disease states," commented Dr. Joseph Gabriele.
Delivra™, the unique Canadian-born technology behind LivRelief and
LivSport therapeutic creams, has improved the lives of thousands of
patients in addition to providing a safer alternative to oral
medication such as pain relief medications. The investment from AIF
will allow Delivra, Inc. to expand the scope of use beyond its current
applications. Delivra products are currently available in the U.S. and
Canada, with additional interest from around the world.
About the Atlantic Innovation Fund
Since its launch in 2001, the Atlantic Innovation Fund (AIF) has been
helping Atlantic Canadians compete in a global knowledge-based economy
through the development and commercialization of new ideas,
technologies, products and services.
About Delivra, Inc.
Headquartered in Burlington, Ontario, Canada, with a research and
development lab in Charlottetown on Prince Edward Island, Delivra, Inc.
is comprised of a team of medical and corporate innovators. Consumers
requiring further information on the various LivRelief™ products or the
results of clinical trials can visit http://www.livrelief.com. For information on LivSport products visit www.livsport.com.
SOURCE: Delivra Inc.
For further information:
Media requiring further information, product samples or photography please call Ameen Ferris, 905-639-7878 or email, email@example.com.